(19)
(11) EP 4 680 739 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24712594.1

(22) Date of filing: 14.03.2024
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61K 38/00(2006.01)
A61K 47/00(2006.01)
B82Y 5/00(2011.01)
A61K 31/00(2006.01)
A61K 39/00(2006.01)
A61P 31/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/00; C12N 15/1135; C12N 2310/141; C12N 2310/344; C12N 2320/32; A61K 9/5161; A61K 31/7105; C07K 2317/622
 
C-Sets:
C12N 2310/321, C12N 2310/3521;
(86) International application number:
PCT/IB2024/052487
(87) International publication number:
WO 2024/189572 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.03.2023 IT 202300004770

(71) Applicants:
  • Istituto Superiore di Sanità
    00161 Roma (IT)
  • Università degli Studi di Roma "La Sapienza"
    00185 Roma (IT)

(72) Inventors:
  • FELLI, Nadia
    00161 Roma (IT)
  • FELICETTI, Federica
    00161 Roma (IT)
  • BIFFONI, Mauro
    00161 Roma (IT)
  • FLEGO, Michela
    00161 Roma (IT)
  • ARASI, Maria Beatrice
    00161 Roma (IT)
  • PALOCCI, Cleofe
    00161 Roma (IT)

(74) Representative: Croce, Valeria 
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)

   


(54) SELECTIVE DELIVERY OF ONCO-SUPPRESSIVE MIRNA (MIR126) TO METASTATIC MELANOMA CELLS RESISTANT TO THERAPIES